Total Liabilities: The total value of all possible claims against the corporation.
Organogenesis (ORGO) had Total Liabilities of $249.17M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$45.46M |
|
$-32.77M |
|
$21.90M |
|
$23.56M |
|
$74.95M |
|
$-29.49M |
|
$-0.13M |
|
$-29.62M |
|
$-29.62M |
|
$-29.63M |
|
$-29.63M |
|
$-29.63M |
|
$-29.63M |
|
$-29.49M |
|
$-23.03M |
|
128.99M |
|
128.99M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$158.13M |
|
$98.60M |
|
$210.78M |
|
$368.90M |
|
$47.65M |
|
$10.37M |
|
$201.52M |
|
|
Total Liabilities |
$249.17M |
$119.74M |
|
$88.39M |
|
$119.74M |
|
129.79M |
|
| Cash Flow Statement Financials | |
$-29.12M |
|
$-2.10M |
|
$-36.17M |
|
$94.33M |
|
$26.94M |
|
$-67.39M |
|
$9.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.32 |
|
-- |
|
-- |
|
0.08 |
|
0.09 |
|
51.83% |
|
-64.87% |
|
-64.87% |
|
-- |
|
-65.16% |
|
-72.09% |
|
$-34.83M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.82 |
|
0.49 |
|
183.51 |
|
-24.75% |
|
-33.52% |
|
-8.03% |
|
-22.77% |
|
$0.92 |
|
$-0.27 |
|
$-0.23 |
|